150
Participants
Start Date
August 29, 2023
Primary Completion Date
February 28, 2025
Study Completion Date
February 28, 2025
Immunotherapy
Immune checkpoint inhibitors in approved indications
RECRUITING
CH de Pau, Pau
RECRUITING
CH Metropole Savoie, Chambéry
RECRUITING
CH Francois Quesnay, Mantes-la-Jolie
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY